PCSA- Processa Pharmaceuticals, Inc.

Name: Processa Pharmaceuticals, Inc. Insider Trading Data
Creator: U.S. Securities and Exchange Commission
License: https://www.sec.gov/privacy#accessibility

Processa Pharmaceuticals, Inc. (PCSA) has 10 insiders with recent SEC Form 4 filings, including 10 buys and 0 sells. PCSA is classified in the Biotechnology industry within the Health Care sector.

Insider Ownership

Role	Insider	Shares	Value	30d
?	Neal James R	100.0K	$208.0K	-
?	Pannu Geraldine	100.0K	$208.0K	-
?	Yorke Justin W	100.0K	$208.0K	-
?	Baluch Khoso	100.0K	$208.0K	-
Other	Bigora Sian	96.0K	$199.7K	-

Activity

Buys and sells only

Transactions

10 filings

Date	Insider	Role	Type	Shares	Price	Value	Chg%	3M	12M
May 29, 2026	Skibsted Russell	Chief Financial Officer	Buy	2,292	$2.57	$5,890.44	+27.1%	-	-
May 29, 2026	Lin Patrick	Chief Business - Strategy Off	Buy	1,582	$2.57	$4,065.74	+20.8%	-	-
May 29, 2026	Young David	Pres. Research &Development	Buy	1,786	$2.57	$4,590.02	+11.6%	-	-
May 29, 2026	Ng George K	Chief Executive Officer	Buy	2,129	$2.57	$5,471.53	+27.2%	-	-
May 29, 2026	Guy Wendy	Chief Administrative Officer	Buy	1,829	$2.57	$4,700.53	+22.8%	-	-
May 15, 2026	Lin Patrick	Chief Business - Strategy Off	Buy	1,369	$2.97	$4,065.93	+22.0%	-	-
May 15, 2026	Young David	Pres. Research &Development	Buy	1,545	$2.97	$4,588.65	+11.2%	-	-
May 15, 2026	Ng George K	Chief Executive Officer	Buy	1,843	$2.97	$5,473.71	+30.7%	-	-
Jan 27, 2025	Ng George K	Chief Executive Officer	Buy	87,200	$0.80	$69,542.00	New	-61.5%	-79.1%
Jan 27, 2025	Young David	Pres. Research &Development	Buy	124,500	$0.80	$99,288.75	+153.9%	-61.5%	-79.1%

Page 1Next →

Insider	Role	Shares	Value	Buys	Sells

Date	Ticker	Insider	Role	Type	Shares	Price	Value	Chg%	SEC